PORCARI, ALDOSTEFANO
 Distribuzione geografica
Continente #
AS - Asia 3.953
EU - Europa 3.944
NA - Nord America 3.608
SA - Sud America 634
AF - Africa 90
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.245
Nazione #
US - Stati Uniti d'America 3.484
IT - Italia 1.691
SG - Singapore 1.611
CN - Cina 1.089
BR - Brasile 512
HK - Hong Kong 506
DE - Germania 394
NL - Olanda 241
SE - Svezia 240
FI - Finlandia 222
GB - Regno Unito 206
VN - Vietnam 203
KR - Corea 171
RU - Federazione Russa 171
FR - Francia 168
PL - Polonia 159
CH - Svizzera 88
IN - India 88
AT - Austria 66
BG - Bulgaria 65
IE - Irlanda 61
CA - Canada 58
AR - Argentina 51
JP - Giappone 50
MX - Messico 42
MA - Marocco 41
TR - Turchia 38
ES - Italia 29
UA - Ucraina 24
BE - Belgio 23
ID - Indonesia 23
BD - Bangladesh 22
CO - Colombia 22
CZ - Repubblica Ceca 18
IR - Iran 16
ZA - Sudafrica 15
SA - Arabia Saudita 14
EC - Ecuador 11
IQ - Iraq 11
RO - Romania 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
GR - Grecia 10
IL - Israele 10
PK - Pakistan 10
PE - Perù 9
TW - Taiwan 9
LT - Lituania 8
MY - Malesia 8
NO - Norvegia 8
CL - Cile 7
DZ - Algeria 6
JO - Giordania 6
UZ - Uzbekistan 6
BY - Bielorussia 5
EG - Egitto 5
KG - Kirghizistan 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
BO - Bolivia 4
GE - Georgia 4
KE - Kenya 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PT - Portogallo 4
SI - Slovenia 4
AL - Albania 3
CU - Cuba 3
DK - Danimarca 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
NI - Nicaragua 3
PH - Filippine 3
PY - Paraguay 3
SM - San Marino 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
GA - Gabon 2
JM - Giamaica 2
LU - Lussemburgo 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NP - Nepal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
Totale 12.219
Città #
Singapore 848
Ashburn 589
Hong Kong 497
Hefei 495
Chandler 363
Trieste 252
Beijing 198
Boardman 193
Milan 175
Seoul 167
Helsinki 163
Munich 162
Dallas 143
Fairfield 143
Los Angeles 129
Zgierz 102
Rome 98
London 96
Columbus 91
Santa Clara 88
Seattle 80
Moscow 72
Bern 71
Ho Chi Minh City 68
Wilmington 68
Houston 67
Woodbridge 67
Sofia 63
Dublin 61
New York 56
Princeton 56
Cambridge 53
Frankfurt am Main 51
Buffalo 50
Hanoi 50
São Paulo 49
Naples 45
Warsaw 44
Nuremberg 43
Vienna 42
The Dalles 41
Council Bluffs 38
San Jose 36
Lappeenranta 35
Redondo Beach 32
Casablanca 29
Turin 29
Ann Arbor 28
Amsterdam 26
Montreal 25
Tokyo 25
Denver 24
Florence 24
Shanghai 24
Brooklyn 23
Jacksonville 23
Udine 23
Paris 22
Phoenix 22
Düsseldorf 21
Chicago 20
Washington 20
Padova 19
Turku 19
Venice 19
Boydton 18
Chennai 18
Palermo 18
Venezia 18
Verona 18
Belo Horizonte 17
Izmir 16
Mumbai 16
Atlanta 15
Bari 15
Bologna 15
Brussels 15
Karlsruhe 15
Orem 15
Roubaix 15
Stockholm 15
Parma 14
Toronto 14
Brasília 12
Da Nang 12
Genoa 12
Poplar 12
Tianjin 12
Wuhan 12
Bremen 11
Mexico City 11
Boston 10
Brescia 10
Camden 10
Grafing 10
Manchester 10
Portsmouth 10
Pune 10
Tehran 10
Valenzano 10
Totale 7.266
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 479
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 364
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 332
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 260
Cardiac amyloidosis: a changing epidemiology with open challenges 251
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 221
Cardiovascular aging: the unveiled enigma from bench to bedside 216
Clinical validation of a coronary surgery technique that minimizes aortic manipulation 203
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 203
The fate of patients having deep sternal infection after bilateral internal thoracic artery grafting in the negative pressure wound therapy era 185
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib 183
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 178
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 166
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy 164
Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia 160
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 158
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy 155
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 154
The (ultra) sound of a burning heart: A matter of speckles 152
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 143
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 140
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 138
Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis 137
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 136
Myocarditis: Which Role for Genetics? 135
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 132
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 126
Grey zones in the supportive treatments of cardiac amyloidosis 126
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 124
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death 123
Validation and Performance Comparison of Two Scoring Systems Created Specifically to Predict the Risk of Deep Sternal Wound Infection after Bilateral Internal Thoracic Artery Grafting 122
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 121
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 121
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors 121
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 118
Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy 116
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 116
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization 115
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 113
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 112
The Arrhythmic Phenotype in Cardiomyopathy 109
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination 107
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca 104
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience 102
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 101
Cardiac amyloidosis: do not forget to look for it 100
Re-Definition of the Epidemiology of Cardiac Amyloidosis 99
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery 97
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 96
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 94
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance 93
Dieci possibili linee future di ricerca e innovazione nell’amiloidosi cardiaca 93
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy 93
Che cos’è l’Amiloidosi? 90
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy 89
Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure 89
Cardiac Amyloidosis 88
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 88
Precision medicine in heart failure no longer a visual theory but a realistic opportunity 88
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones 87
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 82
Restrictive cardiomyopathy: definition and diagnosis 81
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years 81
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery 81
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis 80
Update 2022 dell’Expert Opinion della Società Italiana di Cardiologia su miocarditi, pericarditi e vaccini contro il COVID-19 80
Atrial electro-functional predictors of incident atrial fibrillation in cardiac amyloidosis 80
Editorial for the article: Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 79
Clinical Use of Biomarkers in Cardiac Amyloidosis 77
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 77
One-Year Risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis 77
Lung damage in SARS-CoV-2 patients: An autopsy study in the era of vaccination 77
Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis 76
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 76
Cardiac amyloidosis: when to suspect and how to confirm 75
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 75
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide 74
Comparison of 99mTc-DPD Scintigraphy, CMR Imaging, and Echocardiography in Patients With V30M-Associated Hereditary Transthyretin Amyloidosis 74
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 70
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis 70
Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis 70
Transthyretin cardiac amyloidosis 70
Myocardial perfusion in cardiac amyloidosis 69
Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017 69
Patologie acute del pericardio 68
Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici 67
Management of hypertrophic cardiomyopathy 66
Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine 65
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 65
Filling the gap in epidemiology, management and clinical course of COVID-19 vaccination-related pericarditis 65
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis 64
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis 64
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 62
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis 62
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 62
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 62
Trends of hypertrophic cardiomyopathy-related mortality in United States young adults: a nationwide 20-year analysis 60
The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium–glucose cotransporter 2 inhibitors? 60
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 59
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 56
Totale 11.553
Categoria #
all - tutte 44.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 52 19 16 75 22 38
2021/2022538 28 35 47 28 31 42 34 31 67 37 63 95
2022/20231.357 72 161 152 192 106 188 35 122 159 35 90 45
2023/20241.844 164 92 97 146 138 145 265 235 44 98 213 207
2024/20253.867 136 178 381 303 330 273 286 244 403 555 329 449
2025/20264.223 699 619 712 759 620 754 60 0 0 0 0 0
Totale 12.643